Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DepoCyte for CNS Relapse in ALL or Aggressive Lymphoma
NCT00199108Phase 3Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Apr 2004
- Primary completion
- Jun 2008
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal cytarabine in acute lymphoblastic leukemia (ALL), Burkitt lymphoma (BL), sponsored by Goethe University Frankfurt. Started Apr 2004; status: completed.
02
Drugs
liposomal cytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)Burkitt lymphoma (BL)
Beyond the preview
Go deeper on NCT00199108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199108.